Organization (Industry)
pfm medical gmbh
ClinicalTrials.gov lists pfm medical gmbh as lead sponsor of 10 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers pfm medical gmbh: 10 lead-sponsored trials and 2 legal-entity registrations.
Disease areas (11)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Heart Defects, Congenital | 4 |
| Pelvic Organ Prolapse | 3 |
| Breast Neoplasms | 2 |
| Cystocele | 2 |
| Ductus Arteriosus, Patent | 2 |
Showing 5 of 11 disease areas.
Trials by start year as sponsor or collaborator (10)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2022 | 2 |
| 2019 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2011 | 1 |
| 2010 | 1 |
| 2009 | 1 |
| 2006 | 1 |
| 2002 | 1 |
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 3 hit target (n=3) | 1 of 3 on time (n=3) |
Journals published in (8)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions | 2 |
| Geburtshilfe und Frauenheilkunde | 2 |
| Archives of gynecology and obstetrics | 1 |
| European journal of cancer care | 1 |
| European journal of obstetrics, gynecology, and reproductive biology | 1 |
Showing 5 of 8 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 51 | 13 | 2025-11-18 |
FDA recalls (10)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| Multi-Snare Set: 5 mm x 125 cm, REF: 147305; 10 mm x 125 cm, REF: 147310 | Class II | 2026-04-21 |
| Rapid Centesis Catheter, 5 Fr x 7 cm Catheter, Ref No. M7513 Product Usage: Short term percutaneous fluid drainage | Class II | 2014-10-20 |
| ASEPT Pleural Drainage System, Pleural Drainage Catheter Kit, Ref No. P09080001, M7001 Product Usage: The pfm medical ASEPT Pleural Drainage System is a tunneled, long term catheter used to drain accumulated fluid from the pleural cavity in order to relieve symptoms associated with pleural effusions. | Class II | 2014-10-20 |
| ASEPT 600 ml Drainage Kit, Ref No. 622287, M7052 Product Usage: The ASEPT Drainage Kit is an accessory to be used to connect to the ASEPT Pleural or Peritoneal Drainage Catheter to drain fluid from the chest or abdomen. | Class II | 2014-10-20 |
| Micro Introducer Kit, 5F Micro Introducer Kit, Ref No. M4005 Product Usage: These introducers are used for the percutaneous introduction of therapeutic devices, such as PICCS. The PFM CT PICC catheter is indicated for short or long term peripheral access to the central venous system for intravenous therapy, and power injection of contrast media. | Class II | 2014-10-20 |
Showing 5 of 10 recalls.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 2 | 2022-02-25 |
Manufacturing and distribution sites (1)
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| PFM Medical GmbH | COLOGNE North Rhine-Westphalia, DE | FDA |
Organization relationships (2)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Aix Scientifics | Co sponsors trial with | 1 |
| MDT Medical Device Testing GmbH | Co sponsors trial with | 1 |
Latest dated events (77)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-04-21 | FDA recall | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-11-18 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-11-11 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-04-08 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-04-08 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 77 events.
Biomarker capability evidence (12)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| MPG | Trial sponsor | Named in trial inclusion criteria |
| MPG | Trial sponsor | Named in trial exclusion criteria |
| MPG | Trial sponsor | Named in trial exclusion criteria |
| MPG | Trial sponsor | Named in trial exclusion criteria |
| MPG | Trial collaborator | Named in trial exclusion criteria |
Showing 5 of 12 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.